These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 30471410)

  • 1. RGD-modified polymer and liposome nanovehicles: Recent research progress for drug delivery in cancer therapeutics.
    Cheng Y; Ji Y
    Eur J Pharm Sci; 2019 Feb; 128():8-17. PubMed ID: 30471410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RGD peptide conjugated liposomal drug delivery system for enhance therapeutic efficacy in treating bone metastasis from prostate cancer.
    Wang F; Chen L; Zhang R; Chen Z; Zhu L
    J Control Release; 2014 Dec; 196():222-33. PubMed ID: 25456829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RGD conjugated liposome-hollow silica hybrid nanovehicles for targeted and controlled delivery of arsenic trioxide against hepatic carcinoma.
    Fei W; Zhang Y; Han S; Tao J; Zheng H; Wei Y; Zhu J; Li F; Wang X
    Int J Pharm; 2017 Mar; 519(1-2):250-262. PubMed ID: 28109899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sequential treatment of drug-resistant tumors with RGD-modified liposomes containing siRNA or doxorubicin.
    Jiang J; Yang SJ; Wang JC; Yang LJ; Xu ZZ; Yang T; Liu XY; Zhang Q
    Eur J Pharm Biopharm; 2010 Oct; 76(2):170-8. PubMed ID: 20600887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RGD-modified pH-sensitive liposomes for docetaxel tumor targeting.
    Chang M; Lu S; Zhang F; Zuo T; Guan Y; Wei T; Shao W; Lin G
    Colloids Surf B Biointerfaces; 2015 May; 129():175-82. PubMed ID: 25851582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antilung cancer effect of ergosterol and cisplatin-loaded liposomes modified with cyclic arginine-glycine-aspartic acid and octa-arginine peptides.
    Wu M; Huang T; Wang J; Chen P; Mi W; Ying Y; Wang H; Zhao D; Huang S
    Medicine (Baltimore); 2018 Aug; 97(33):e11916. PubMed ID: 30113492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Temperature-triggered tumor-specific delivery of anticancer agents by cRGD-conjugated thermosensitive liposomes.
    Kim MS; Lee DW; Park K; Park SJ; Choi EJ; Park ES; Kim HR
    Colloids Surf B Biointerfaces; 2014 Apr; 116():17-25. PubMed ID: 24441178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The design of peptide-amphiphiles as functional ligands for liposomal anticancer drug and gene delivery.
    Kuang H; Ku SH; Kokkoli E
    Adv Drug Deliv Rev; 2017 Feb; 110-111():80-101. PubMed ID: 27539561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RGD-fatty alcohol-modified docetaxel liposomes improve tumor selectivity in vivo.
    Li Y; Zheng X; Sun Y; Ren Z; Li X; Cui G
    Int J Pharm; 2014 Jul; 468(1-2):133-41. PubMed ID: 24709214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted delivery of a novel palmitylated D-peptide for antiglioblastoma molecular therapy.
    Li C; Shen J; Wei X; Xie C; Lu W
    J Drug Target; 2012 Apr; 20(3):264-71. PubMed ID: 22233211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RGD Peptide-Based Target Drug Delivery of Doxorubicin Nanomedicine.
    Sun Y; Kang C; Liu F; Zhou Y; Luo L; Qiao H
    Drug Dev Res; 2017 Sep; 78(6):283-291. PubMed ID: 28815721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Preparation and evaluation of RGD and TAT co-modified paclitaxel loaded liposome].
    Gao B; Mu W
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2014 Aug; 39(8):769-74. PubMed ID: 25202944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Updates on the use of liposomes for active tumor targeting in cancer therapy.
    Yan W; Leung SS; To KK
    Nanomedicine (Lond); 2020 Feb; 15(3):303-318. PubMed ID: 31802702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased tumor targeted delivery using a multistage liposome system functionalized with RGD, TAT and cleavable PEG.
    Mei L; Fu L; Shi K; Zhang Q; Liu Y; Tang J; Gao H; Zhang Z; He Q
    Int J Pharm; 2014 Jul; 468(1-2):26-38. PubMed ID: 24709209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liposome-based glioma targeted drug delivery enabled by stable peptide ligands.
    Wei X; Gao J; Zhan C; Xie C; Chai Z; Ran D; Ying M; Zheng P; Lu W
    J Control Release; 2015 Nov; 218():13-21. PubMed ID: 26428462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MRI-visible liposome nanovehicles for potential tumor-targeted delivery of multimodal therapies.
    Ren L; Chen S; Li H; Zhang Z; Ye C; Liu M; Zhou X
    Nanoscale; 2015 Aug; 7(30):12843-50. PubMed ID: 26022345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent progress in biomedical applications of RGD-based ligand: From precise cancer theranostics to biomaterial engineering: A systematic review.
    Alipour M; Baneshi M; Hosseinkhani S; Mahmoudi R; Jabari Arabzadeh A; Akrami M; Mehrzad J; Bardania H
    J Biomed Mater Res A; 2020 Apr; 108(4):839-850. PubMed ID: 31854488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liposomalized oligopeptides in cancer therapy.
    Asai T; Oku N
    Methods Enzymol; 2005; 391():163-76. PubMed ID: 15721380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RGD-based strategies for selective delivery of therapeutics and imaging agents to the tumour vasculature.
    Temming K; Schiffelers RM; Molema G; Kok RJ
    Drug Resist Updat; 2005 Dec; 8(6):381-402. PubMed ID: 16309948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A targeted liposome delivery system for combretastatin A4: formulation optimization through drug loading and in vitro release studies.
    Nallamothu R; Wood GC; Kiani MF; Moore BM; Horton FP; Thoma LA
    PDA J Pharm Sci Technol; 2006; 60(3):144-55. PubMed ID: 17089683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.